Private sector in the driving seat as Europe reforms health systems
This article was originally published in Clinica
Despite having acquired a highly unpopular image in the US, elements of managed care will become widespread throughout Europe over the next 10 to 15 years. If they are to rise to the challenge of providing better quality care at lower cost, European countries will be forced to allow much greater private sector participation in healthcare delivery in the future, according to speakers at the Economist Healthcare Conference held last week in London.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.